32 results
425
RPHM
Reneo Pharmaceuticals Inc
13 May 24
Business combination disclosure
9:38am
, Executive Officers and Corporate Governance”, “Item 11. Executive Compensation”, “Item 12. Security Ownership of Certain Beneficial Owners and Management … be in compliance, if elected as a director of the corporation, and will comply with, all applicable publicly disclosed corporate governance, conflict
8-K
EX-99.1
RPHM
Reneo Pharmaceuticals Inc
13 May 24
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
9:14am
, as amended on April 26, 2024, including under the sections entitled “Item 10. Directors, Executive Officers and Corporate Governance”, “Item 11. Executive
8-K
RPHM
Reneo Pharmaceuticals Inc
13 May 24
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
9:14am
and Corporate Governance”, “Item 11. Executive Compensation”, “Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
8-K
EX-2.1
RPHM
Reneo Pharmaceuticals Inc
13 May 24
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
9:14am
, and will comply with, all applicable publicly disclosed corporate governance, conflict of interest, confidentiality, stock ownership and trading guidelines
8-K
EX-99.2
RPHM
Reneo Pharmaceuticals Inc
13 May 24
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
9:14am
and Corporate Governance”, “Item 11. Executive Compensation”, “Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder
8-K
go73t02l
2 Aug 22
Departure of Directors or Certain Officers
7:40am
DEF 14A
acr7sc8xyed
22 Apr 22
Definitive proxy
4:05pm
10-K
k4g b4c28bprxu
23 Mar 22
Annual report
4:38pm
10-K
EX-10.11
5n0wo
23 Mar 22
Annual report
4:38pm
8-K
mhbq b8gcqpkbj7u
24 Jan 22
Departure of Directors or Certain Officers
4:05pm